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of Medical Research, Australian National University, Canberra, AustraliaABSTRACT The a1 and b1a subunits of the skeletal muscle calcium channel, Cav1.1, as well as the Ca2þ release channel,
ryanodine receptor (RyR1), are essential for excitation-contraction coupling. RyR1 channel activity is modulated by the b1a
subunit and this effect can be mimicked by a peptide (b1a490–524) corresponding to the 35-residue C-terminal tail of the
b1a subunit. Protein-protein interaction assays confirmed a high-affinity interaction between the C-terminal tail of the b1a and
RyR1. Based on previous results using overlapping peptides tested on isolated RyR1, we hypothesized that a 19-amino-acid
residue peptide (b1a490–508) is sufficient to reproduce activating effects of b1a490–524. Here we examined the effects of
b1a490–508 on Ca2þ release and Ca2þ currents in adult skeletal muscle fibers subjected to voltage-clamp and on RyR1 channel
activity after incorporating sarcoplasmic reticulum vesicles into lipid bilayers. b1a490–508 (25 nM) increased the peak Ca2þ
release flux by 49% in muscle fibers. Considerably fewer activating effects were observed using 6.25, 100, and 400 nM of
b1a490–508 in fibers. b1a490–508 also increased RyR1 channel activity in bilayers and Cav1.1 currents in fibers. A scrambled
form of b1a490–508 peptide was used as negative control and produced negligible effects on Ca2þ release flux and RyR1
activity. Our results show that the b1a490–508 peptide contains molecular components sufficient to modulate excitation-
contraction coupling in adult muscle fibers.INTRODUCTIONCav1.1, also known as the dihydropyridine receptor, is an
atypical voltage-gated Ca2þ channel that is expressed in
the sarcolemma and the transverse tubule system of skeletal
muscle (1,2). Cav1.1 is a multimeric complex, composed of
a principal a1s subunit and auxiliary a2-d1, g1, and b1a
subunits (1,3–6).
The a1s subunit is a 160-kDa transmembrane protein, the
primary role of which is acting as a voltage sensor (5,7,8),
but is also capable of working as an L-type Ca2þ channel
(4,9,10). Upon depolarization, the a1s subunit undergoes
conformational changes that are detected by the directly
apposed Ca2þ release channel, the ryanodine receptor
(RyR1), located on the surface of the sarcoplasmic reticulum
(SR) (7,11–15). The response to this Cav1.1-RyR molecular
coupling is a transient release of Ca2þ from the SR and result-
ing elevation in cytosolic Ca2þ concentration that develops
rapidly upon depolarization and results in the activation of
the actin-myosin contractile machinery (11,16–19). This
functional and structural relationship between the Cav1.1
and RyR1 is a critical part of an electro-mechanical process
known as excitation-contraction (E-C) coupling (20,21).
The a2-d1 (140 and 24–27 kDa, respectively) and g1
(30 kDa) subunits appear to have modest effects on a1sSubmitted May 13, 2013, and accepted for publication November 13, 2013.
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0006-3495/14/02/0535/13 $2.00conduction function (22) and regulation of depolarization-
induced Ca2þ release (23), with little or no effect on a1s tar-
geting and tetrad formation (24–26), but the significance of
these auxiliary subunits, as of this writing, is still not well
understood (2,24).
On the other hand, the b1a subunit, a 54-kDa cytosolic
protein expressed exclusively in skeletal muscle, binds to
the intracellular loop between repeats I and II of the a1s
and is essential for almost all aspects of a1s function and
expression (27–29). Earlier studies showed that myotubes
formed from b-null mouse myoblasts have a low density
of L-type Ca2þ current, low density of intramembrane
charge movement, and lack E-C coupling (27,30,31).
Additional experiments using microinjection techniques
of b1a subunit combined with field stimulation-induced
fluo-3 transient measurements in adult skeletal muscle
fibers demonstrated that the b1a subunit significantly
increased the amplitude of fluo-3 transients without major
changes in its kinetics (32). Studies using skeletal muscle
from b1-null zebrafish larvae revealed that b1a deter-
mines the efficient arrangement of Cav1.1 in tetrads
abutting the RyR1, and thus functional Cav1.1-RyR1
coupling (33,34).
In addition to the regulation of a1s function and expres-
sion by the b1a subunit, there are in vitro studies that indi-
cate that b1a subunit also binds to the RyR1 and can
strengthen E-C coupling (35). Previous studies using b1a/
b2a chimeras and truncation mutants indicated that the
C-terminal of the b1a subunit contains unique elementshttp://dx.doi.org/10.1016/j.bpj.2013.11.4503
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38). Deletion of the 35-residue C-terminal tail of b1a exog-
enously expressed in b1a-null mouse myotubes produced a
significant reduction in the amplitude of depolarization-
induced Ca2þ transients (36). Rebbeck et al. (39), using af-
finity chromatography, ryanodine binding assays, and RyR1
single-channel measurements in artificial lipid bilayers,
demonstrated the ability of a peptide corresponding to the
final 35-residue of b1a C-terminus (b1a490–524) to bind
to RyR1 as well as the ability of the full-length b1a subunit
and its C-terminal tail peptide to increase the activity of
RyR1. In a recent study, Kuranasekara et al. (40), using
NMR spectroscopy, affinity chromatography, and RyR1 sin-
gle-channel measurements, identified specific hydrophobic
surface residues L496, L500, and W503 within b1a490–
524 as critical for binding to and activation of RyR1. These
extensive in vitro studies revealed that these hydrophobic
residues are critical for b1a-RyR1 interaction; however,
the role of these hydrophobic residues in E-C coupling
in adult skeletal muscle fibers has not previously been
reported.
In this report, we tested the hypothesis that a 19-residue
C-terminal tail peptide from the b1a subunit (b1a490–
508) containing the hydrophobic residues L496, L500, and
W503 is sufficient to reproduce the effect of the 35-residue
C-terminal tail of the b1a subunit. Here we used adult
mammalian skeletal muscle fibers in culture subjected to
simultaneous high-speed fluo-4 confocal measurements
and voltage-clamp experiments to examine the properties
of the voltage-dependent Ca2þ release flux and Cav1.1
Ca2þ current in fibers dialyzed with the b1a490–508 peptide
or a scrambled form of the 19-residue peptide. We also used
SR vesicles incorporated into lipid bilayers and demon-
strated that the b1a490–508 peptide increased RyR1 chan-
nel activity. Our results show that the b1a490–508 peptide
contains molecular components sufficient to modulate E-C
coupling between Cav1.1 and RyR1 in adult functioning
muscle fibers. A preliminary account of some of these
results has been presented at the Biophysical Society
Meeting (41).MATERIALS AND METHODS
Ethical approval
All animals were housed in a pathogen-free area at the University of Mary-
land (Baltimore, MD). The animals were euthanized according to autho-
rized procedures of the Institutional Animal Care and Use Committee,
University of Maryland, by regulated delivery of compressed CO2 overdose
followed by cervical dislocation.Flexor digitorum brevis fiber preparation
Fibers were prepared using enzymatic dissociation of flexor digitorum
brevis (FDB) muscles of 6–7-week-old C57BL mice, and were cultured
as previously described in Liu et al. (42) and Olojo et al. (43).Biophysical Journal 106(3) 535–547Peptide synthesis
The amino-acid sequence of the synthetic peptides corresponding
to the peptide fragment of C-terminal tail b1a subunit of Cav1.1:
490VQVLTSLRRNLSFWGGLEA508 (b1a490–508) and its scrambled
form: 490RVFRGELSQLNLGLTASVW508 (b1a490–508 scrambled) were
synthesized at The Biopolymer/Genomics Core Facility at the University
Of Maryland School Of Medicine, with purification of 96–100% by high-
performance liquid chromatography and mass spectroscopy.Solutions
Whole-cell Ca2þ current measurements were carried out as previously
described in Olojo et al. (43) and Prosser et al. 44). The bath (external)
solution contained 150 mM TEA-CH3SO3, 2 mM CaCl2, 10 mM HEPES,
1 mM MgCl2, 0.001 mM TTX, 1 mM 4-aminopiridine, and 0.025 mM
BTS (n-benzyl-p-toluene sulphonamide), pH-adjusted to 7.4 with CsOH.
The standard pipette solution (internal) contained 140 mM Cs-CH3SO3,
10 mM HEPES, 20 mM EGTA, 6 mM MgCl2, 11.5 mM CaCl2, 4 mM
Na2ATP, 14 mM creatine phosphate, 0.3 mM Na2GTP, and 0.1 mM leupep-
tin, solution pH-adjusted to 7.4 with CsOH to obtain a buffered solution.
Fibers were dialyzed for 20 min via the patch pipette with 50 mM fluo-4
5Kþ. Where noted, 6.25–400 nM b1a490–508 or scrambled b1a490–508
was included in the internal solution. Fibers were dialyzed for exactly
20 min before the start of data acquisition.Electrophysiology and data analysis
Membrane current measurements were performed using the whole-cell
configuration of the patch-clamp technique (45) with modifications for
mammalian FDB fibers detailed in Prosser et al. (44) and Wang et al.
(46) using a EPC-10 patch-clamp amplifier (HEKA Instruments, Bellmore,
NY). Whole-cell Ca2þ currents were typically low-pass-filtered at 3–
10 kHz (3-pole Bessel filter). Currents were sampled at 10 kHz. Linear
capacitive and ionic currents were routinely subtracted by a P/4 protocol
from a subholding potential of –120 mV. Current amplitude was normalized
to the linear fiber capacitance, which was estimated using the following
equation:
C ¼ Q=V:
The value of C was determined by measuring linear capacitive current
elicited by a55 mV, 80-ms test pulse from the holding potential and inte-
grating the area under the capacitive current trace to estimate Q.Fluo-4 high-speed line-scan (x-t) confocal
microscopy
Fluo-4 fluorescence measurements were carried out on an LSM 5 Live
System (Carl Zeiss, Jena, Germany) as previously described in Prosser
et al. (47) and Olojo et al. (43,48). Average intensity of fluorescence as
a function of time (F(x,t)) within a selected segment of the scan line within
a fiber was measured using the software LSM IMAGE EXAMINER (Carl
Zeiss). The average F0 value in each line segment before test pulse is used
to scale fluo-4 fluorescence in the same region as F/F0. Careful examina-
tion of the changes in both F0 and DF indicated that both were changing
over the course of an experiment and corresponding corrections were car-
ried out according to the detailed procedure described in Olojo et al. (43).
Time courses of free Ca2þ concentrations and Ca2þ release fluxes were
calculated from Ca2þ transients after correction for both dye saturation
and for the kinetic delay in dye equilibrium using calculation methods
previously described in Olojo et al. (43) and Prosser et al. (47). Under
conditions when the dye is not at equilibrium with the cytosolic free
b1aV490–A508 Fragment Potentiates Voltage-Dependent Ca Release 537Ca2þ, the time course of cytosolic free Ca2þ concentration ([Ca]cyto(t)) is
given by
½CacytoðtÞ ¼KDd

1=koffd

dFðtÞ=dt
þ FðtÞ  Fmin

Fmax  FðtÞÞf
(1)
(see Klein et al. (49), Eq. 5, with rearrangements), where KDd is the disso-
ciation constant for Ca2þ from the indicator dye, koffd is the off-rate
constant for Ca2þ dissociation from the dye, F is the fiber fluo-4 fluores-
cence signal, and Fmax and Fmin are the fluorescence at saturating and
zero free Ca2þ, respectively. When the concentration is changing slowly,
the following condition applies:
½CazKDdððF FminÞ=ðFmax  FÞÞ: (2)
Then, average [Ca2þ]cyt (t) is derived from F(t)/F0 (50) as

Ca2þ

cyto
ðtÞ ¼ Ca2þ
cytoð0Þ
ðFðtÞ=F0Þ
þ 1=koffd

dðFðtÞ=F0Þ=dt

;
(3)
where [Ca2þ]cyto(0) is free cytosolic [Ca
2þ] at resting levels. This equation as-
sumes that the dye is far from saturation by Ca2þ, which appears justified for
fluo-4 considering that [Ca2þ]cyto was always much lower than the value of
fluo-4’sKD previously determined using in situ calibrations (47). [Ca
2þ]cyto(0)
was set equal to 0.081 mM, the average value measured in parallel studies
using indo-1 in voltage-clamped FDB fibers without b1a490–508 peptide.
Calculation of Ca2þ release flux
During the time course of the rate of change of [Ca-EGTA] under the condi-
tions of 20mMEGTAwith added Ca2þ in the pipette, EGTA is still themajor
binding site for releasedCa2þ. In that case,d[Ca-EGTA](t)/dtprovides a good
approximation to the rate of SRCa release in the fiber, and will be used in the
Ca2þ release calculations presented here. For Ca2þ binding to EGTA,
d½Ca-EGTAðtÞ=dt ¼ kone ½CaðtÞ ½EGTAðtÞ
 koffe ½Ca-EGTAðtÞ;
(4)
where kone and koffe are on- and off-rate constants for Ca
2þ binding to
EGTA.
Because [EGTA](t) ¼ [EGTA]tot  [Ca-EGTA](t),
d½Ca-EGTAðtÞ=dt ¼ kone ½CaðtÞ
½EGTAtot
 ½Ca-EGTAðtÞ
 koffe ½Ca-EGTAðtÞ:
(5)
Equation 5 was solved numerically using [Ca2þ]cyto(t) from Eq. 3, and the
Euler method to calculate the time course of d[Ca-EGTA](t)/dt, which was
used as the time course of the rate of Ca2þ release from the SR during the
voltage-clamp pulses. [EGTA]tot in the fiber was assumed to be 70% of that
in the pipette solution. [EGTA] and [Ca-EGTA] inside the fiber at the start
of each pulse were calculated from [EGTA]/[Ca-EGTA] ¼ KDe/[Ca2þ] and
from the conservation of total EGTA. The parameter values used in our cal-
culations were koffd ¼ 90 s1 (51), kone ¼ 15 (mM s)1 (50), and koffe ¼
1.2 s1 (EGTA KD ¼ 0.08 mM).
Analysis of the voltage dependence of Ca2þ release flux and
Ca2þ current activation
Peak Ca2þ release rate was calculated and plotted as a function of voltage
(R/V plots). The data were fit by a single Boltzmann function, described by
the equation (47)RðVÞ ¼ Rmax=

1þ expVhalf  V

k

; (6)
where Rmax is the maximum release rate, Vhalf defines the potential when
R ¼ 0.5 Rmax, and 1/k is a measure of the steepness of the R-V relationship.
Ca2þ current density valueswereplotted as a functionofvoltage (I/Vplots).
These I/V plotswerefit by amodifiedBoltzmann-Ohmic equation (43,44,52),
I ¼ GmaxðV  VrevÞ=

1þ exp V  Vhalf

k

; (7)
whereGmax is the maximum conductance, V is the membrane potential, Vrev
is the reversal potential, Vhalf is the half-activation potential, and k is a
measure of the steepness.
SR vesicle isolation, single-channel recording, and analysis
Rabbit skeletal muscle SR vesicles were isolated and single channel record-
ings were carried out as described previously in Karunasekara et al. (40).
Homogenates of back and leg muscle were run through a discontinuous
sucrose gradient to collect heavy SR vesicles, which were centrifuged
and resuspended in 20 mM imidazole, 300 mM sucrose, and standard pro-
tease inhibitor cocktail, pH 7.4.
For single-channel recordings, SR vesicles were incorporated into lipid
bilayers with a cis (cytoplasmic) solution of 250 mM CsCH3O3S, 20 mM
CsCl, 1.0 mMCa2þ, and 10 mMTES, pH 7.4, and a trans (luminal) solution
of 30 mM CsCH3O3S, 20 mM CsCl, 1.0 mM Ca
2þ, and 10 mM TES, pH
7.4. After RyR1 incorporation, the Csþ was equilibrated by trans addition
of 200 mM CsCH3O3S. Sequentially, the free [Ca
2þ] in the cis solution was
reduced to 10 mM using an amount of BAPTA determined using a Ca2þ
electrode and 2 mM ATP was added to the cis solution. The bilayer poten-
tial, Vcis-Vtrans, was switched between þ40 and 40 mVevery 30 s for 10–
15 min before and after addition of either 10 or 100 nM peptide. Channel
activity was measured from >90 s of current recording under every condi-
tion using the program CHANNEL 2 (developed by P. W. Gage and M.
Smith, John Curtin School of Medical Research, Australian National Uni-
versity, Canberra, Australia). The records were filtered at 1 KHz with acqui-
sition at 5 KHz. Analysis was done with an additional filter of 500 Hz. The
threshold levels for channel opening were set to exclude baseline noise at
~20% of the maximum single channel conductance, and open probability
(Po), mean open time (To), and mean closed time (Tc) were measured.Statistical analysis
Statistical analysis was performed using the softwares ORIGINPRO 8.0
(OriginLab, Northampton, MA) and EXCEL (Microsoft, Richmond,
WA). All data are presented as mean5 SE unless otherwise noted. Statis-
tical significance was assessed using the parametric two-sample t-test or the
nonparametric Mann-Whitney rank-sum test, or ANOVA, as appropriate.
To reduce the effects of variability in control single-channel activity param-
eters (PoC, TcC, ToC) and to evaluate parameters after b1a peptide (PoP, TcP,
ToP), data were expressed as the difference between the logarithmic values,
i.e., log10 rel Po ¼ log10PoP – log10PoC. Significance was set at p < 0.05.RESULTS
Depolarization-evoked fluo-4 transients in control
fibers, and fibers dialyzed with b1a490–508
peptide or b1a490–508 scrambled peptide
In the first experiments, we aimed to evaluate the effects of
b1a490–508 peptide on orthograde E-C coupling (i.e.,
Cav1.1 to RyR signaling) and used depolarization-induced
fluo-4 transients as readout. FDB muscle fibers isolated
from C57BL mice were voltage-clamped at a holdingBiophysical Journal 106(3) 535–547
538 Herna´ndez-Ochoa et al.potential of80mV. In these experiments, 50 mMfluo-4 was
included in the patch-pipette solution, and was allowed to
diffuse into the fiber for exactly 20 min after establishment
of the whole-cell configuration and before starting data
acquisition. Fig. 1 shows average fluo-4 transients obtained
from control fibers (Fig. 1 A); fibers dialyzed withA
B
C
FIGURE 1 Depolarization-induced fluo-4 transients from control,
scrambled, and b1a490–508-dialyzed skeletal muscle fibers. (A) Average
fluo-4 DF/F0 records in control fibers, N ¼ 9. (B) Fibers dialyzed with
25 nM scrambled peptide (b1a490–508 scrambled), N ¼ 9. (C) Fibers dia-
lyzed with 25 nM b1a490–508 peptide, N ¼ 8. Transients were elicited
using step depolarizations to the levels indicated in the figure using the
whole-cell configuration of the patch-clamp technique. The Ca2þ indicator
and peptides were delivered via the patch pipette. The intracellular dialysis
of b1a490–508 peptide potentiates depolarization-induced fluo-4 transients
in skeletal muscle fibers. To see this figure in color, go online.
Biophysical Journal 106(3) 535–54725 nM of the scrambled peptide (b1a490–508 scrambled,
Fig. 1 B); and fibers dialyzed with 25 nM b1a490–508 pep-
tide. Data were obtained using series of 80 ms voltage-clamp
step depolarizations, with a 30 s interval between pulse appli-
cations. All measurements were carried out with application
of an initial and final voltage pulse to 20 mV and a series
of pulse voltages in between 60 mV to þ20 mVat 20-mV
step increments. The bracketing set of pulses to 20 mV
applied before, during, and after series of pulses from 60
to þ20 mV were used to monitor for stability of the fiber,
as used in earlier work (43,48). The 20-min time interval
for diffusion of pipette solution into the fiber before starting
data acquisition and the 30-s interval between application of
successive pulses were strictly adhered to in all experiments.
Confocal line-scan images were acquired at 100 ms/line syn-
chronized to start 300 ms before each of the pulses during
step depolarizations.
Using the voltage protocol described above, a detectable
fluo-4 fluorescence change was typically first detected in
most fibers with pulses to above 40 mV, and saturated
with pulses to ~0 mV (Fig. 1, A–C). The scrambled peptide
did not produce an evident change in the amplitude of the
fluo-4 transients (Fig. 1 B), while the b1a490–508 peptide
at 25 nM increased the amplitude of DF/F0 fluo-4 transients
(Fig. 1 C) when compared to the control counterpart.Depolarization-induced Ca2D transients are
increased by dialysis with 25 nM b1a490–508
peptide
The correction for possible changes in the fiber over the
course of each experiment as described previously in Olojo
et al. (43,48) was applied to obtain F/F0 records, and these
records were used to calculate the free cytosolic Ca2þ con-
centration (free [Ca2þ]) for each fiber using Eq. 3. Average
records of free [Ca2þ] are shown in Fig. 2, A–C, represent-
ing control fibers, fibers dialyzed with 25 nM scrambled
peptide, and fibers dialyzed with 25 nM b1a490–508 pep-
tide, respectively. The b1a490–508 peptide at 25 nM
increased the amplitude of calculated free [Ca2þ].Intracellular dialysis with 25 nM b1a490–508
increases the peak SR Ca2D release flux
The Ca2þ release flux in each fiber was then calculated from
its free [Ca2þ] waveform. For each fiber, the rate of Ca2þ
release from the inside of the SR into the cytosol was calcu-
lated using Eq. 5. Fig. 3 A presents the average of the re-
cords of the Ca2þ release flux from control fibers (N ¼ 9),
while corresponding data for scrambled peptide (25 nM
b1a490–508 scrambled) are presented in Fig. 3 B (N ¼ 9).
Fig. 3 C presents average of the records of the Ca2þ release
flux obtained after dialysis of 25 nM b1a490–508 peptide
(N ¼ 8). The b1a490–508 peptide at 25 nM increased the
magnitude of the peak Ca2þ release (peak Ca2þ release
AB
C
FIGURE 2 Free [Ca2þ] waveforms from control, scrambled, and
b1a490–508-dialyzed fibers. (A) Free [Ca2þ] waveform derived from
Fig. 1 A for control fibers. (B) Corresponding free [Ca2þ] waveform for
fibers dialyzed with the scrambled peptide (b1a490–508 scrambled), data
derived from Fig. 1 B. (C) Free [Ca2þ] waveform for the b1a490–508 pep-
tide, data derived from Fig 1 C. All calculations for the free [Ca2þ] wave-
forms were obtained using Eq. 3. To see this figure in color, go online.
A
B
C
FIGURE 3 Ca2þ release fluxes from control, scrambled, and b1a490–
508-dialyzed fibers. (A) Time course of Ca2þ release flux in control fibers,
data derived from Fig. 2 A. (B) Fibers dialyzed with scrambled peptide
(b1a490–508 scrambled), data derived from Fig. 2 B. (C) Fibers dialyzed
with b1a490–508 peptide, data derived from Fig. 2 C. Ca2þ release flux
waveform was calculated using Eq. 5. Comparison of the sets of data
show a significant potentiation of Ca2þ release flux signals by addition of
b1a490–508 peptide. To see this figure in color, go online.
b1aV490–A508 Fragment Potentiates Voltage-Dependent Ca Release 539at þ20 mV for control fibers ¼ 72.25 9.8 mM ms1, with
scrambled peptide ¼ 80.3 5 15.3 mM ms1 and for
b1a490–508-dialyzed fibers ¼ 107.8 5 11.5 mM ms1).Fibers dialyzed with 25 nM b1a490–508 exhibit
increased peak Ca2D release without change in its
voltage dependence
Using data obtained from each of the fibers used in Fig. 3,
A–C, average values of the peak release rate were calculatedand plotted as a function of voltage (R-V profiles in Fig. 4 A).
The datawere fit by a singleBoltzmann function described by
Eq. 6 (see Materials andMethods). Average5 SE values for
Rmax, Vhalf, and k parameters were: 72.2 5 9.8 mM ms
1,
23.7 5 2.3 mV, and 13.2 5 1.5 mV; 80.3 5
15.3 mM ms1, 21.45 5.1 mV, and 13.95 1.8 mV; and
107.8 5 11.5 mM ms1, 20.0 5 2.8 mV, and 11.3 5
1.1 mV for control, b1a490–508 scrambled-dialyzed fibers,Biophysical Journal 106(3) 535–547
AB
FIGURE 4 b1a490–508 at 25 nM maximally potentiates voltage-depen-
dent Ca2þ release flux. (A) Average peak Ca2þ release flux records plotted
versus voltage (R-V relationships) for control fibers (black symbols), fibers
dialyzed with the b1a490–508 scrambled peptide (green symbols), and
fibers dialyzed with 25 mM b1a490–508 peptide (red symbols). (Contin-
uous lines through the symbols) Best fits to a single Boltzmann function,
Eq. 6; see Results for parameter details. (B) Concentration dependence of
peak Ca2þ release flux for b1a490–508-dialyzed fibers at 6.25, 25, 100,
and 400 nM of peptide. These results show a biphasic plot of maximum
peak Ca2þ release flux relative to its control (R/Rc) as a function of concen-
tration of the b1a490–508 peptide. R/Rc values were calculated using
maximum release rate (Rmax) fitted values from Ca
2þ release flux versus
voltage (R-V) relationships obtained for each of the concentrations tested
for b1a490–508 peptide and its scrambled version and then divided by
mean Rmax value derived from corresponding control recordings (i.e.,
no peptide added). Dialysis of 6.25, 25, 100, and 400 nM b1a490–508 pro-
duced negligible, 49.1, 13.7, and 10.9% potentiation of the peak Ca2þ
release flux, respectively. The asterisk (*) indicates P < 0.05 vs. b1a490–
508 scrambled. To see this figure in color, go online.
540 Herna´ndez-Ochoa et al.and b1a490–508-dialyzed fibers, respectively. This analysis
reveals a significant 49% enhancement (N ¼ 8; P < 0.05)
in the maximum peak Ca2þ release with the addition of
25 nM b1a490–508 when compared to the control fibers.
The Vhalf values shown above indicate a nonsignificant
change in the voltage-dependence of Ca2þ release arising
from addition of b1a490–508 and that of its scrambled
form when compared to Vhalf of the control fibers
(Fig. 4 A). It is important to note that the scrambled peptide
did not produce a significant change in the amplitudeBiophysical Journal 106(3) 535–547of the Ca2þ release relative to control measurements
(P > 0.05).The modulation of peak SR Ca2D release exhibits
a biphasic dependence on concentration of
dialyzed b1a490–508
In another series of experiments (Fig. 4 B), fibers were dia-
lyzed with either 6.25, 25, 100, or 400 nM of b1a490–508 or
its corresponding scrambled version, each run in parallel
with control internal solution without any added b1a490–
508 peptide. A pulse sequence as indicated in Fig. 1 was
used with 20-mV increments from 60 mV to þ20 mV
and a reference pulse to 20 mV at the start, middle, and
end of the sequence. Correction for changes with time was
identical to that used for data obtained in Fig. 1. Fig. 4 B pre-
sents averages of peak Ca2þ release flux profiles obtained
from fibers dialyzed with 6.25, 25, 100, and 400 nM of
b1a490–508 peptide or its scrambled version (N ¼ 4–6
fibers per group). The dialysis of 6.25 nM b1a490–508
showed no change in the peak Ca2þ release rates when
compared to fibers dialyzed with b1a490–508 scrambled
peptide (P > 0.05), while dialysis of 25 nM b1a490–508
produced a statistically significant enhancement (49.1%)
in the peak Ca2þ release flux when compared to the scram-
bled counterpart (P < 0.05). The dialysis with 100 nM
b1a490–508 produced a nonsignificant 13.7% enhancement
in the peak Ca2þ release flux values when compared to
the scrambled counterpart (P > 0.05). Further increasing
the concentration of b1a490–508 to 400 nM resulted in a
smaller nonsignificant (10.9%) potentiation of the peak
Ca2þ release flux when compared to scrambled counterpart
(P > 0.05). These results show the biphasic dependence of
peak Ca2þ release rate plotted against the concentration of
b1a490–508, with maximum potentiation of peak Ca2þ
release occurring at 25 nM of the b1a490–508 peptide.Whole cell L-type Ca2D channel current is also
modulated by the dialysis of b1a490–508 in a
biphasic manner
Wenext examinedwhether b1a490–508 also caused changes
in the whole-cell Ca2þ currents carried by the Cav1.1 chan-
nels. Fig. 5A shows representativemacroscopic Ca2þ current
traces from a control fiber (black trace; N¼ 9), b1a490–508
scrambled-dialyzed fiber (green trace; N ¼ 10), and a
b1a490–508-dialyzed fiber (red trace, 25 nM; N¼ 11) using
step depolarizations lasting 80 ms applied from a holding
potential of 80 mV. Traces shown were obtained at 0 mV,
where the maximum inward amplitude occurred during
step depolarizations. Fig. 5 B shows the average peak Ca2þ
current density plotted against voltage (I/V) from control
(black circles), b1a490–508 scrambled-dialyzed fibers
(green circles), and b1a490–508-dialyzed fibers (red cir-
cles). Addition of 25 nM b1a490–508 induced ~81%
AC
B FIGURE 5 Intracellular dialysis of b1a490–508
enhances macroscopic Ca2þ current in FDB
fibers. (A) Representative macroscopic Ca2þ cur-
rent traces from control fibers (black trace), fibers
dialyzed with 25 nM b1a490–508 scrambled pep-
tide (green trace), and fibers dialyzed with 25 nM
b1a490–508 peptide (red trace) elicited by a test
depolarization to 0 mV from a holding potential
of 80 mV shown above traces. Macroscopic cur-
rents were elicited by 80-ms depolarizing pulses
using 2 mM Ca2þ as the charge carrier. Because
the magnitude of the Ca2þ current was dependent
on fiber size, aggregate current data are presented
as current densities normalized to cell capaci-
tance. (Vertical dashed lines) Time used to mea-
sure average current density values to create I/V
plots. (B) I/V relationships of average data from
control (black symbols, N ¼ 9), fibers dialyzed
with 25 nM b1a490–508 scrambled peptide
(green symbols, N ¼ 10), and fibers dialyzed
with 25 nM b1a490–508 (red symbols, N ¼ 11).
(Solid lines through symbols of the I/V profiles
in panel B) Least-squares fits of the data to
a modified Boltzmann-Ohmic equation, Eq. 7;
see Results for parameter details. (C) Summary
of the effects of the b1a490–508 peptide and its
scrambled version at different concentrations
on whole-cell Ca2þ current elicited by a test depo-
larization to 0 mV from a holding potential
of 80 mV. Data is presented as mean current
amplitude in fibers dialyzed with b1a490–508
peptide or its scrambled version divided by
mean current amplitude from control fibers (no
peptide added). Relative strong potentiation (79%) of Ca2þ current was found at 25 nM of the b1a490–508 peptide but not at lower and higher concen-
trations. The asterisk (*) indicates P < 0.05 vs. b1a490–508 scrambled. To see this figure in color, go online.
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illustrated in Fig. 5 B. The solid lines through the I/V curves
in Fig. 5 B are least-squares fits of the data to a modified
Boltzmann-Ohmic equation (Eq. 7). Average parameter
values for Gmax, Vhalf, k, and Vrev for control fibers were
91.95 2.7 pA/mV, 12.15 1.5 mV, 3.35 0.1 mV, and
40.1 5 0.8 mV. Average values for Gmax, Vhalf, k, and Vrev
for fibers dialyzed with the b1a490–508 scrambled peptide
were 88.1 5 2.9 pA/mV, 11.8 5 2.4 mV, 3.0 5
0.2mV, and 39.45 0.8mV. The corresponding sets of values
for fibers dialyzed with the b1a490–508 were 109.8 5
12.2 pA/mV, 13.7 5 0.9 mV, 3.4 5 0.4 mV, and
60.05 3.1 mV. Fibers dialyzed with b1a490–508 exhibited
a significant 24% enhancement on Gmax when compared to
fibers dialyzed with the scrambled version of b1a peptide
(P< 0.05). The above results also indicate that the enhance-
ment of the Ca2þ current caused by addition of b1a490–508
is voltage-independent, judging by the negligible effects on
both Vhalf and kBoltzmann’s parameters of the Ca
2þ channel
conductance.
In a different set of experiments, FDB fibers were dia-
lyzed with 6.25, 25, 100, or 400 nM of b1a490–508 peptide
or its corresponding scrambled version. Each run was per-
formed in parallel with control internal solution without
any added b1a490–508 peptide. Maximum inward Ca2þcurrent density was measured at 0 mV, using a 80-ms
test pulse applied from a holding potential of 80 mV.
Fig. 5 C presents mean Ca2þ current density amplitude in
fibers dialyzed with b1a490–508 peptide or its scrambled
version divided by mean current amplitude from control
fibers (relative ICa density). These results show a biphasic
dependence of Ca2þ current density plotted as function of
the concentration of C-terminus b1a490–508 peptide, with
potentiation of maximum inward Ca2þ current occurring
at 25 nM, but little or no effect at lower and higher concen-
trations. These results are similar to the Ca2þ release exper-
iments shown in Fig. 4 B, and allow us to propose that the
potentiating effect of the peptide on Ca2þ current could
result from an indirect mechanism via retrograde signaling.The b1a490–508 peptide increases RyR1 channel
activity in lipid bilayers
After the evaluation of the effects of the b1a490–508 pep-
tide on voltage-dependent Ca2þ release and L-type Ca2þ
currents in skeletal muscle, we next wanted to test whether
the b1a490–508 peptide was indeed acting directly on RyR1
channels. RyR1 channel activity was recorded using SR ves-
icles incorporated into artificial lipid bilayers. The b1a490–
508 peptide and its scrambled version were tested at 10 andBiophysical Journal 106(3) 535–547
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were chosen because we have previously demonstrated
that 10 nM and 100 nM b1a490–524 and b1a474–A508 pro-
duce maximal increases in RyR1 activity (40).
The traces in Fig. 6 A show that channel activity
at þ40 mV increases upon addition of 100 nM b1a490–
508 peptide, whereas the scrambled peptide does not alter
channel activity (Fig. 6 B). The average effect of the pep-
tides was the same at þ40 and 40 mV (see Table S1 in
the Supporting Material), and hence data were combined
in all averages for simplicity. The average relative Po (deter-
mined for individual channels) is significantly greater in the
presence of 10 and 100 nM b1a490–508 (dark-gray bars;
N ¼ 6–15) control channel activity and greater than the ef-
fect of the scrambled peptide (light-gray bars; N ¼ 6–15).
Similar to the effect of b1a490–524 (39) and b1a474–508
(40) on RyR1 activity, addition of 10 and 100 nM
b1a490–508 peptide increase channel activity by ~2–2.5-
fold. The increase in open probability is due to a 1.8- and
2.5-fold decrease in mean closed time (Fig. 6 D) for 10
and 100 nM, with no change in the mean open time
(Fig. 6 E). This suggests that b1a490–508 binding decreases
RyR1 dwell time in the closed state, but does not interactFIGURE 6 The b1a490–508 peptide increases the activity of RyR1 channels.
upward from the closed (c) to maximum open (o) level, before (control) and af
peptide (B). Open probability is shown in the right-hand corner of each trace. (C
ferences between the logarithm of Po after addition of the peptide (log10PoP) and
peptide addition. (D) Average relative mean closed time (log10rel Tc) and (E) ave
as the average log10 rel Po (above). (N ¼ 6–15 experiments/bar; *P < 0.05 vs.
Biophysical Journal 106(3) 535–547with the open state of the channels. Overall, these results
demonstrate that the b1a490–508 peptide, like other active
b1a C-tail peptides (40), increases RyR1 activity at cyto-
plasmic Ca2þ concentrations present in skeletal muscle dur-
ing excitation-contraction coupling.DISCUSSION
All isoforms of the b-subunit of the voltage-gated Ca2þ
channels, including the skeletal muscle-specific b1a, can
be divided into five regions based on the amount of identity
between them. Two highly conserved regions (regions 2 and
4) are flanked by highly divergent N- and C-termini (regions
1 and 5, respectively), and are linked by region 3 (28,29,53).
The second and fourth regions are homologous to the Src
homology 3 (SH3) and guanylate kinase (GK) domains,
respectively. The GK domain contains a hydrophobic
groove, termed the a-interaction domain-binding pocket,
which is essential for binding to the cytoplasmic I-II loop
of Cav1.1 a1 subunit (54,55). Previous studies using b-chi-
meras and truncation mutants indicated that the C-terminal
of the b1a subunit (region 5) contained unique elements
critical for both binding and modulation of the RyR1(A and B) Three-second (3 s) traces of RyR1 activity at þ 40 mV, opening
ter addition of 100 nM b1a490–508 peptide (A) or b1a490–508 scrambled
) Average relative open probability (log10 rel Po) is the average of the dif-
the logarithm of the control Po (log10PoC), where PoC was measured before
rage relative mean open time (log10 rel To) were calculated in the same way
control, #P < 0.05 vs. b1a490–508 scrambled.)
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b1a produced a significant reduction in the amplitude of
depolarization-induced Ca2þ transients when expressed in
b1a-null mouse myotubes (36,37).
Here we describe, for the first time to our knowledge, the
effects of a the b1a C-terminal tail peptide on depolariza-
tion-induced global SR Ca2þ release detected by high-speed
confocal microscopy and on Cav1.1 Ca2þ currents in whole-
cell voltage-clamped adult FDB skeletal muscle fibers.
We also confirmed the activity of the same b1a490–508 pep-
tide on RyR1 channel activity using skeletal muscle SR ves-
icles incorporated into artificial lipid bilayer membranes.
b1a490–508 is a peptide corresponding to a 19-residue pep-
tide identical in sequence to the corresponding residues in
the C-terminal tail of the b1a subunit of the Cav1.1. This
peptide contains specific hydrophobic surface residues
L496, L500, and W503, which recent reports indicate are
critical for binding to and activation of RyR1 (39,40); how-
ever, to our knowledge, the role of these hydrophobic resi-
dues in E-C coupling in adult skeletal muscle fibers has
not previously been reported.
Mice null for the b1a subunits die at birth from asphyxia
due to lack of respiratory skeletal muscle activity, preclud-
ing the investigation of the mechanisms of E-C coupling
in adult skeletal muscle (27). Fortunately, a large number
of previous reports have used myotubes as a cell model to
examine the effects of the b1a subunit, or peptides from
b1a on E-C coupling (34–38,56,57). Primary isolated
or cultured myotubes are in many respects valuable cell
models to study muscle development and plasticity, because
they are robust and more easily accessible with molecular
biology methods than terminally differentiated, adult mus-
cle fibers (58). However, for studies of E-C coupling and
Ca2þ release, these myotube cultures may not display all as-
pects of these phenomena as present in fully mature fibers
(58,59). Therefore, studies on adult fibers as carried out
here provide an important compliment to both the previous
myotube studies, as well as to the studies on isolated RyR1
channels in phospholipids bilayers.
Our results using the b1a490–508 peptide, which con-
tains hydrophobic surface residues L496, L500, and W503
of the C-terminal of the b1a subunit, are consistent with
the hypothesis that these residues are critical for E-C
coupling. The control peptide, having the 19 residues of
the b1a490–508 peptide in a scrambled sequence, did not
modify the amplitude or voltage dependence of depolariza-
tion-evoked Ca2þ release. Interestingly, the randomly
scrambled peptide had the following properties: L496 was
retained, L500 was replaced by asparagine (N), and W503
was changed to leucine (L; see Materials and Methods for
details on peptides sequence). Note that despite preserving
two hydrophobic residues in the three locations, this peptide
was unable to modulate any parameter of the depolarization-
evoked Ca2þ release compared to the properties observed
in the absence of peptide. These results indicate that thesequence and number of hydrophobic residues within the
C-terminal of the wild-type b1a subunit are critical for
E-C coupling regulation.
Using acute microinjection of full-length wild-type b1a
subunit combined with Ca2þ transient measurements in
adult skeletal muscle fibers, Garcı´a et al. (32) demonstrated
that the full-length b1a subunit significantly increased the
amplitude of both intracellular Ca2þ transients and L-type
Ca2þ currents. In this work, we find that b1a490–508 pep-
tide also increased the amplitude of both Ca2þ transients
and Ca2þ currents. The amplitude of the Ca2þ current was
distinctly larger at all the voltages tested, although the
time course was not significantly modified. For instance,
the time to peak of Ca2þ current at 0 mV averaged 62 5
10 ms (N ¼ 7) in control fibers versus 64 5 8 ms (N ¼ 7)
in fibers dialyzed with b1a490–508 peptide. A potentiating
effect was also found for the Ca2þ release, supporting the
view that this short region of the C-terminus of b1a subunit
contains important molecular determinants for E-C coupling
modulation.
Interestingly, both Ca2þ release and L-type Ca2þ current
showed biphasic concentration dependence. Strong potenti-
ation was found at 25 nM of the peptide but not at higher
concentrations. We believe that this effect could be due to
peptide aggregation in the cell at higher concentrations.
The peptide is far more hydrophobic than previous peptides
(>100 nM) used by our laboratories (39,40,60,61). The
potentiating effect of the b1a-490–508 peptide on both
Ca2þ current and Ca2þ release was not accompanied by
changes in their voltage dependence. In this regard, Garcı´a
et al. (32) found no effect of the b1a subunit on charge
movement recorded in adult skeletal muscle fibers, and
suggested that b-subunits improve the efficiency of E-C
coupling such that the same number of voltage sensors
would activate more Ca2þ release channels. The capability
of the b1a subunit (32) and the b1a490–508 peptide (results
from this article) to potentiate both Ca2þ release and Ca2þ
currents demonstrates that the C-terminus of the b1a subunit
fine-tunes both the amount of Ca2þ that is released by the
SR via RyR1 and the amount of Ca2þ that enters the fiber
via Cav1.1 channels. The above observations support the
notion of a modular function for b1a. In this regard, recent
work by Dayal et al. (62) supports this view, and suggests
that the cooperative effect between the SH3 domain and
C-terminus of b1a is required to turn on the Cav1.1
voltage-sensing function.
Assuming that b1a490–508 only interacts with RyR1 in
muscle fibers, the enhancement of both depolarization-
evoked L-type Ca2þ current and RyR1 Ca2þ release by
the b1a490–508 peptide could be explained by at least
two alternative hypothetical mechanisms, neither of which
is entirely satisfactory:
1. In the first mechanism (Fig. 7 A), the added peptide binds
only to RyR1 Ca2þ release channels that are not coupledBiophysical Journal 106(3) 535–547
AB
FIGURE 7 Two hypothetical models to explain
the potentiating effects of b1a490–508 peptide
on Ca2þ release and Cav1.1 current. Cartoon
representation of critical elements for skeletal
muscle type excitation-contraction coupling:
voltage-gated L-type Ca2þ channel Cav1.1 (also
known as the dihydropyridine receptor (DHPR)),
the b1a subunit (b1a), and the calcium release
channel, ryanodine receptor type-1 (RyR1). T-tu-
bule membrane: invagination of skeletal muscle
plasma membrane, sarcoplasmic reticulum (SR)
membrane; cRyR1 stands for RyR1s coupled
to Cav1.1 and nRyR1 stands for RyR1s not
coupled to Cav1.1; (blue curved arrow) orthograde
signaling from Cav1.1 to cRyR1; (green curved ar-
row) retrograde signaling from cRyR1 to Cav1.1.
The cartoon also shows additional key regulatory
proteins FKBP, S100A1, and calmodulin. (A) Mod-
ulation of not-coupled calcium release channels
only. In this scenario, the b1a peptide binds exclu-
sively to nRyR1 and results in increased nRyR1
channel activity in response to Ca2þ released by
an adjacent cRyR1, which is activated by Cav1.1
via T-tubule depolarization. Note that this scenario
does not explain L-type Ca2þ current modulation;
see text for additional information. (B) Modulation
of both not-coupled and coupled calcium release
channels, resulting in an increase in both Ca2þ
release and Ca2þ entry. A prerequisite for this sce-
nario is that Cav1.1a subunits are not fully satu-
rated with b1a subunits. In this case the b1a
peptide binds to both nRyR1 and to cRyR1 that
lack a b1a subunit. The binding of the b1a490–
508 peptide to Cav1.1/cRyR1 complexes lacking
the b1a subunit results in potentiated Ca2þ release,
and by retrograde signaling, in enhanced Ca2þ
entry via L-type Ca2þ channel. As in the scenario
shown in panel A, the binding of b1a peptide to
nRyR1 will also potentiate Ca2þ release. To see
this figure in color, go online.
544 Herna´ndez-Ochoa et al.(nRyR1) to Cav1.1 channels. In this scenario, b1a490–
508 peptide would bind to such nRyR1s, modulating
their open probability in response to Ca2þ released
by adjacent Ca2þ release channels that are coupled
(cRyR1) to Cav1.1, and are thus activated during fiber
depolarization (14,63–65). This mechanism is similar
to the situation of single isolated RyR1 Ca2þ release
channels in phospholipid bilayers, where full-length
b1a subunit or C-terminal b1a490–524, b1a474–508
(40,66), or b1a490–508 (this article) peptide addition
augments the RyR1 channel open probability under con-
trol conditions where channels were partially activated
by 10 mM cytoplasmic Ca2þ. Based on the clear activa-
tion of isolated RyR1 by b1a490–508 in bilayers, it
seems reasonable that such a similar interaction should
also occur between b1a490–508 and nRyR1s in muscle
fibers. It is also likely that b1a490–508 would not in-
crease resting SR Ca2þ release because we have shown
that b1a490–524 does not alter RyR1 activity in lipid bi-
layers when the free cytoplasmic Ca2þ is 0.1 mM, and weBiophysical Journal 106(3) 535–547show here that other actions of the two peptides on RyR1
activity in bilayers are very similar. Therefore, we would
predict that b1a490–508 would potentiate voltage-acti-
vated Ca2þ release, but not increase resting SR Ca2þ
leak. Additionally, Ca2þ release via nRyR1s that are acti-
vated due to voltage-dependent activation of neighboring
cRyR1s could augment Ca2þ release without altering its
voltage dependence, as observed here.
Although the binding of b1a490–508 to nRyR1s
may explain the potentiation of SR Ca2þ release
by b1a490–508, the interaction of b1a490–508 with
nRyR1s does not explain the increased L-type Ca2þ cur-
rent also caused by b1a490–508 without additional
ad hoc assumptions. The increased Ca2þ current could
be explained by binding of b1a490–508 to nRyR1s if
nRyR1s communicate with their neighboring cRyR1s
by direct lateral coupling (67), instead of by released
Ca2þ (Fig. 7 A). In that case (not shown), binding of
b1a490–508 to an nRyR1 could not only increase
nRyR1 activation during depolarization as described
b1aV490–A508 Fragment Potentiates Voltage-Dependent Ca Release 545above, but could also increase a hypothetical retrograde
signal back to the neighboring cRyR1 to increase its acti-
vation. In turn, the increased activation of the cRyR1
could increase the retrograde feedback to its coupled
Cav1.1, and thus increase the L-type Ca2þ current (not
shown in Fig. 7 A). However, this possibility is entirely
speculative because there is no evidence, as of this
writing, for such retrograde signaling from nRyR1s to
cRyR1s.
2. A second hypothetical mechanism for potentiated Ca2þ
current and Ca2þ release with added b1a490–508 is
that b1a490–508 binds to both cRyR1s and nRyR1s
(Fig. 7 B). One possibility is that not all Cav1.1 a-sub-
unit/RyR complexes include an associated b-subunit or
that b-binding/unbinding to Cav1.1/RyR complexes is
a dynamic process in adult muscle fibers. For example,
Garcı´a et al. (68), using whole-cell patch-clamp Ca2þ
current measurements from skeletal muscle vesicles,
found that the amplitude of L-type Ca2þ currents were
doubled by exposure to additional b1a subunits dialyzed
via the patch pipette. One implication of that study is that
Cav1.1 a1 subunits are not fully saturated with b1a (69).
This could occur if the affinity of Cav1.1 a-subunits for
b1a subunits was reduced after the channel has reached
the T-tubule membranes (70) and formed tetrads, which
requires the b1a subunit (33,34). In fact, the presence
of b-subunits in skeletal muscle, not associated with a1
subunits, has indeed been described in tissue homoge-
nates (71), and could be consistent with a possible loss
of b1a subunits after tetrad formation. In this scenario,
the exogenously added b1a490–508 peptide would bind
to cRyR1s in Cav1.1/RyR1 complexes lacking the b-sub-
unit, resulting in potentiated depolarization-induced
Ca2þ release and, by retrograde feedback to Cav1.1,
increased Ca2þ current. As above, b1a490–508 would
also bind to and potentiate activation of nRyR1s. Both
this and the above mechanism would predict that appli-
cation of b1a490–508 to the muscle fiber interior would
have similar effects as application of the entire b1a sub-
unit, consistent with the similarity of these observations
of the effects of b1a490–508 and previously observed
effects of the entire b1a subunit (32).
Finally, we cannot exclude the possibility that the added
peptide may compete with the endogenous b1a subunit
and displace the links between Cav1.1a-b1a-RyR1 and
thus alter Ca2þ release during depolarization. However,
the fact that in muscle fibers full-length b1a (32) has similar
effects as b1a490–508 (32) makes this possibility unlikely,
because replacement of endogenous full-length b1a with
added full-length b1a would not be expected to alter proper-
ties of the system.
Using electron microscopy and single particle analysis
of Cav1.1 complexes (a1, a2, and b1a), Szpyt et al. (72)
identified new features discernible in the electron densitythat accommodate the atomic coordinates of a voltage-gated
channel and of the b-subunit in a single docking possibility
that redefines the Cav1.1 a1-b1a interaction. The b1a sub-
unit appeared more closely associated to the membrane
and adjacent to the Cav1.1 a1 subunit. It was suggested
that this adjacent positioning keeps the b-subunit close
to the cytoplasmic domain of RyR1 and localizing the
Cav1.1 a1 subunit to the membrane (72). Where exactly
on the RyR1 does the b1a490–508 peptide bind? Previ-
ous work has demonstrated that the polybasic motif
KKKRR_ _R in residues K3495-R3502 of a RyR1 fragment
(M3201-W3661) pulls down b1a and facilitates E-C
coupling (35). Despite these numerous studies, details about
the role of the b1a subunit in relation to the Cav1.1-RyR1
interaction in skeletal muscle E-C coupling remain unclear
and will form the basis of future investigations.CONCLUSIONS
Overall, our results support the modular hypothesis (62)
that the proximal region (b1a490–508) of the b1a subunit
C-terminal tail regulates the coupling among voltage sensor
activation, RyR1 Ca2þ release activation, and Cav1.1chan-
nel opening in adult skeletal muscle fibers.SUPPORTING MATERIAL
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